Evaluation of pre-analytic heat treatment protocol used in the CDC Nijmegen-Bethesda assay for heat inactivation of extended half-life hemophilia treatment products

類似資料

• Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors
  著者:: Miller, C. H., 等
  出版事項: (2018)
• Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors
  著者:: Payne, Amanda B., 等
  出版事項: (2019)
• Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab
  著者:: Miller, Connie H., 等
  出版事項: (2020)
• Mutation analysis of a cohort of US patients with hemophilia B
  著者:: Li, Tengguo, 等
  出版事項: (2014)
• The CDC Hemophilia B mutation project mutation list: a new online resource
  著者:: Li, Tengguo, 等
  出版事項: (2013)